» Articles » PMID: 39792613

Multi-miRNAs-Mediated Hepatic Lepr Axis Suppression: A Pparg-Dicer1 Pathway-Driven Mechanism in Spermatogenesis for the Intergenerational Transmission of Paternal Metabolic Syndrome

Overview
Journal Adv Sci (Weinh)
Date 2025 Jan 10
PMID 39792613
Authors
Affiliations
Soon will be listed here.
Abstract

Bisphenol A (BPA) is an "environmental obesogen" and this study aims to investigate the intergenerational impacts of BPA-induced metabolic syndrome (MetS), specifically focusing on unraveling mechanisms. Exposure to BPA induces metabolic disorders in the paternal mice, which are then transmitted to offspring, leading to late-onset MetS. Mechanistically, BPA upregulates Srebf1, which in turn promotes the Pparg-dependent transcription of Dicer1 in spermatocytes, increasing the levels of multiple sperm microRNAs (miRNAs). Several of these miRNAs are highly expressed in a synchronized manner in liver of the offspring. miR149-5p, miR150-5p, and miR700-5p target a specific region in the Lepr 3'UTR, termed "SMITE" ("Several MiRNAs Targeting Elements"), to negatively regulate Lepr. These inherited anti-Lepr miRNAs, also referred to inherited anti-Lepr miRNAs (IAL-miRs), modulate hepatic steatosis, and insulin signaling through the Lepr regulatory Igfbp2, Egfr, and Ampk. Furthermore, IAL-miRs inhibit Ccnd1 not only via binding to "SMITE" but also via Lepr-Igfbp2 axis, which contribute to hepatocyte senescence. These pathological processes interact in a self-reinforcing cycle, worsening MetS in the paternal BPA-exposed offspring. The findings reveal mechanism wherein lipid metabolism reprogramming in spermatocytes-induced perturbations of sperm miRNAs, triggered by BPA, leads to intergenerational inheritance of paternal MetS through suppression of the hepatic Lepr axis in the offspring.

Citing Articles

Multi-miRNAs-Mediated Hepatic Lepr Axis Suppression: A Pparg-Dicer1 Pathway-Driven Mechanism in Spermatogenesis for the Intergenerational Transmission of Paternal Metabolic Syndrome.

Lin Y, Ni X, Zhu L, Lin Y, Peng C, Lei Z Adv Sci (Weinh). 2025; 12(9):e2410831.

PMID: 39792613 PMC: 11884570. DOI: 10.1002/advs.202410831.

References
1.
Alkhazaali-Ali Z, Sahab-Negah S, Boroumand A, Tavakol-Afshari J . MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease. Biomed Pharmacother. 2024; 177:116899. DOI: 10.1016/j.biopha.2024.116899. View

2.
Song P, Duan J, Ding J, Liu J, Fang Z, Xu H . Cellular senescence primes liver fibrosis regression through Notch-EZH2. MedComm (2020). 2023; 4(5):e346. PMC: 10442476. DOI: 10.1002/mco2.346. View

3.
Hogh K, Craig M, Uy C, Nygren H, Asadi A, Speck M . Overexpression of PPARγ specifically in pancreatic β-cells exacerbates obesity-induced glucose intolerance, reduces β-cell mass, and alters islet lipid metabolism in male mice. Endocrinology. 2014; 155(10):3843-52. DOI: 10.1210/en.2014-1076. View

4.
Bhushan B, Banerjee S, Paranjpe S, Koral K, Mars W, Stoops J . Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model. Hepatology. 2019; 70(5):1546-1563. DOI: 10.1002/hep.30696. View

5.
Cohen P, Yang G, Yu X, Soukas A, Wolfish C, Friedman J . Induction of leptin receptor expression in the liver by leptin and food deprivation. J Biol Chem. 2005; 280(11):10034-9. DOI: 10.1074/jbc.M413684200. View